DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Heier J.
Review of Lucentis (ranibizumab, rhuFab V2) phase I/II trial results: 6 month treatment of exudative AMD.
IOVS 2004; 45: ARVO E-Abstract 1109
We do not assume any responsibility for the contents of the web pages of other providers.